Adhitya Veeraraghavan

407 posts

Adhitya Veeraraghavan banner
Adhitya Veeraraghavan

Adhitya Veeraraghavan

@abveera

Health Sector Head at Edelman in India. All tweets & RTs reflect personal views, not those of my organization.

Mumbai, India Katılım Aralık 2013
721 Takip Edilen184 Takipçiler
Adhitya Veeraraghavan retweetledi
Teena Thacker
Teena Thacker@Teensthack·
The govt has done away with the requirement of clinical investigation for new drugs having significant therapeutic advance over the current standard care and have already got the regulatory approval in the US, UK, Japan, Australia, Canada or the European Union. @CDSCO_INDIA_INF
Teena Thacker tweet media
English
36
63
138
21.7K
Rupsa Chakraborty
Rupsa Chakraborty@RupsaChak·
Thrilled to announce that I'm undertaking a short work experience stint at the newsroom of the #BritishMedicalJournal, one of the world's most reputed journals, in London! It's a dream come true for a health reporter to work with such brilliant editors & reporters #CheveningAward
Rupsa Chakraborty tweet mediaRupsa Chakraborty tweet mediaRupsa Chakraborty tweet media
London, England 🇬🇧 English
18
0
95
2.1K
Teena Thacker
Teena Thacker@Teensthack·
Soaring temp in many parts of India are fuelling demand for medications that manage chronic conditions-medications for high blood pressure (antihypertensives), cholesterol (lipid-lowering drugs), and blood clotting (platelet aggregation inhibitors). m.economictimes.com/industry/healt…
Teena Thacker tweet media
English
2
2
9
1.2K
Dinesh S. Thakur
Dinesh S. Thakur@d_s_thakur·
@thakurfdn 13/n So, the million-dollar question is why is the Govt. still flogging the DPCO as the primary tool to fix prices, instead of trying to fix the cartelization issue through better enforcement? And that, my friends is how influence manifests. Its not all obvious sometimes.
English
3
18
30
1.6K
Adhitya Veeraraghavan retweetledi
Dinesh S. Thakur
Dinesh S. Thakur@d_s_thakur·
Longish 🧵👇 The Govt. (@nppa_india) recently announced the creation of a committee to relook the issue of drug pricing in the country. As usual the focus is going to be the Drug Price Control Order (DPCO) which is notified under the Essential Commodities Act, 1955: 1/n
Dinesh S. Thakur tweet media
English
14
139
254
50.2K
Adhitya Veeraraghavan retweetledi
Karthik 🇮🇳
Karthik 🇮🇳@beastoftraal·
❤️ Lovely piece of work for Starbucks India, by the agency Edelman India. Starbucks has used the same theme earlier too, particularly in an ad for Starbucks UK, late-2019/early-2020, made by the creative agency Iris (see next tweet). 1/7
English
27
164
921
160.6K
Adhitya Veeraraghavan
Adhitya Veeraraghavan@abveera·
Brilliant episode. It covers risks, trade-offs, data, digital, India's biotech future, cancer & NCDs. Listen to understand the tough odds of discovery & research, shareholder expectations and the deadlines of looming generic competition.
SK@sruthijith

“99% of the things we do in research don’t work. Actually, it’s even worse… it’s one out of a thousand. You have to have a really strong comfort with failure. We fail a lot. That failure can’t dissuade you from trying again.” That’s a CEO who did $50 billion in sales last yr.

English
0
0
2
481
Comms News
Comms News@CommsNews_·
Saswati Panigrahi joins Castrol India as Head of Communications. @SaswatiPanig was previously at Bayer
English
12
1
22
0
Leroy Leo D'Souza
Leroy Leo D'Souza@LeroyLeo7·
Professional update: After nearly two years at @livemint, which I left last month, I have now joined @Reuters and am based out of Bengaluru. In my new role, I would be covering US health and pharmaceutical companies.
English
30
1
165
0

Keşfet

@CDSCO_INDIA_INF @RupsaChak @Teensthack @d_s_thakur @thakurfdn @nppa_india @abantika77 @ThePrintIndia